Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 6;20(3):162-165.
doi: 10.18502/cjn.v20i3.7692.

Myasthenia gravis and coronavirus disease 2019: A report from Iran

Masoud Etemadifar  1 , Mahsa Akafzadeh-Savari  2 , Mehri Salari  3 , Amirhossein Akhavan Sigari  2 , Sara Ebrahimi-Pelarti  2 , Nahad Sedaghat  2 , Koorosh Etemad  4
Affiliations

Myasthenia gravis and coronavirus disease 2019: A report from Iran

Masoud Etemadifar et al. Curr J Neurol. .

Abstract

Background: Coronavirus disease 2019 (COVID-19) is spreading rapidly and has affected millions of people worldwide. Comorbid diseases have complicated the course of infection and increased mortality. Myasthenia gravis (MG) affects the neuromuscular junctions (NMJs) and can compromise respiratory muscle action, leading to worse clinical outcomes in individuals infected with the COVID-19 theoretically. In this study, the aim is to assess the pattern of COVID-19 infection in patients with MG based on several factors. Methods: This was a prospective cohort study following 150 patients with MG over a six-month period. The patients were monitored for the development of signs and symptoms of the COVID-19 infection. Results: Comparison of the patients infected with COVID-19 with MG and those not infected was performed independently based on age, duration since MG diagnosis, status of thymectomy, and current clinical status of MG disease. Data analysis did not reveal increased susceptibility or increased severity of COVID-19 illness based the criteria assessed. Conclusion: COVID-19 related deaths and susceptibility were not related to age, thymectomy status, and disease duration in patients with MG.

Keywords: COVID-19; Myasthenia Gravis; Neurology; Thymectomy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lazzari C, Shoka A, Nusair A, Rabottini M. Psychiatry in time of COVID-19 pandemic. Psychiatr Danub. 2020;32(2):229–35. - PubMed
    1. Wenninger S, Schoser B. Myasthenia gravis: Current status of antibody diagnostics and aspects on refractory myasthenia gravis. Fortschr Neurol Psychiatr. 2018;86(9):551–8. [In German] - PubMed
    1. Anand P, Slama MCC, Kaku M, Ong C, Cervantes-Arslanian AM, Zhou L, et al. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020;62(2):254–8. - PMC - PubMed
    1. Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, Howard JF, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020;412:116803. - PMC - PubMed
    1. Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020;173(12):1027–8. - PMC - PubMed

LinkOut - more resources